Genome Editing Market share research by applications and regions for 2017-2024

26/lug/2017 12:10:50 Kate Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The global Genome Editing Market share report provides numbers for applications and regional segments of the industry covering historical as well as forecast data for decision makers.

As per the medical report “Genome Editing Market Size By Technology (CRISPR/Cas9, Zinc Finger Nucleases (ZFNs), Meganucleases, TALENS), By Application (Hematology, Infectious Disease, Oncology, Muscular Disorders), By End User (Biotech and Pharma, CRO, Research Institutes), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Spain, Russia, Poland, China, Japan, India, Australia, Malaysia, Mexico, Brazil, Argentina, South Africa, Saudi Arabia, Israel), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2016 �“ 2024”, by Global Market Insights, Inc. says, Genome editing industry value, worth USD 2.17 billion in 2015, is set to hit USD 7.5 billion by 2024.

Genome editing market revenue is anticipated to witness a notable surge over the years ahead, driven by the escalating occurrence of cancer and other genetic inherited disorders coupled with mounting demand for personalized medicines. Companies have been spending extensively on R&D activities across the pharma & biotech sectors. In addition, the availability of enhanced healthcare facilities and the introduction of new modes of treatment will offer lucrative avenues for the gene editing market players to expand their business.


Request for a sample of this research report - https://www.fractovia.org/request-sample/499


Considering the geographical landscape, U.S. genome editing market, worth USD 518.5 million in 2015, is slated to expand considerably in the future. A strong growth trend displayed by biotechnology and pharmaceutical firms is expected to boost the industry size.


UK genome editing industry is projected to cross a revenue of USD 744 million by 2024, registering a CAGR of 14.9% over 2016-2024. The high occurrence of chronic disorders among the rising old population will propel the industry development. Increasing occurrence of HIV, hemophilia, and sickle cell anemia will spur the growth of South Africa industry.


Japan genome editing market revenue, worth USD 160 million in 2015, is projected to grow at a rate of 15% over the coming timeframe. Improvement in healthcare amenities and favorable government policies to restrict the spread of infectious diseases will push the business expansion.

Browse key industry insights spread across 150 pages with 90 market data tables & 7 figures & charts from this 2017 report Genome Editing Market in detail along with the table of contents at:

https://www.fractovia.org/news/industry-research-report/gene-editing-market


Genome editing finds varied applications in muscular disorders, hematology, oncology, and infectious ailments. Hematology, which contributed USD 807 million towards gene editing industry share in 2015, is expected to make notable contributions towards the industry revenue even in the future. Oncology is set to record a CAGR of 15.9% over the coming seven years, with the mounting occurrence of various kinds of cancers.


Biotech & pharma firms, contract research organizations, and research institutes are the key end-users of genome editing industry. Biotech & pharma sector, which accounted for more than 58% of gene editing market size in 2015, is expected to witness a substantial surge over the next few years. Rising use of the technology in medicines and therapeutics will boost the revenue.


Make an inquiry for purchasing this report @ https://www.fractovia.org/request-purchase/499


Genome editing makes use of technologies such as meganucleases, CRISPR/Cas9, TALENS, and zinc finger nucleases. CRISPR technology, which dominated the overall market in 2015, is set to surpass USD 3 billion by 2024. The growth can be ascribed to wider applications of the technology in farming and genetic engineering.


Bio Rad Laboratories Inc., Editas Medicine, Sigma-Aldrich, Thermo Fisher Scientific, and Allele Biotechnology are the major players of gene editing market.


Browse Related Report:


Digital Genome Market Size By Product (Sequencing & Analyzer Instruments, DNA/RNA Analysis Kits, Sequencing Chips, Sequencing & Analysis Software, Sample Prep Instruments), By Application (Microbiology [Biological, Clinical, Industrial], Reproductive & Genetic, Transplantation, Livestock and Agriculture, Forensics, Research and Development), By End-Use (Diagnostics & Forensic Labs, Academic Research Institutes, Hospitals, Bio-pharmaceutical Companies), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, Spain, Russia, France, China, Japan, India, Australia, Argentina, Brazil, Mexico South Africa, Saudi Arabia), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 �“ 2024


https://www.gminsights.com/industry-analysis/digital-genome-market


About Fractovia.org:


Fractovia.org is one of India's leading in-house and free news portal. It is fully automated, and operates on a constant premise, interfacing with news sites and offering redesigned breaking features to readers across the globe. Our mission is to offer individuals opportunities for connections with news writers and distributors which they can pursue. We operate by mapping articles pertaining to breaking news, constantly and progressively, against a pre-determined word-based theme, offering important connections to readers and clients, as well as distributors.


Contact Us:

 

Arun Hegde
Corporate Sales, USA
Fractovia.org
Phone: 1-302-846-7766
Email:
 sales@fractovia.org
Web:
https://www.fractovia.org
Contact Us: Facebook | Twitter

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl